Your browser doesn't support javascript.
loading
A living WHO guideline on drugs to prevent covid-19.
Lamontagne, François; Stegemann, Miriam; Agarwal, Arnav; Agoritsas, Thomas; Siemieniuk, Reed; Rochwerg, Bram; Bartoszko, Jessica; Askie, Lisa; Macdonald, Helen; Al-Maslamani, Muna; Amin, Wagdy; Da Silva, Andre Ricardo Araujo; Barragan, Fabian Alberto Jaimes; Bausch, Frederique Jacquerioz; Burhan, Erlina; Cecconi, Maurizio; Chacko, Binila; Chanda, Duncan; Dat, Vu Quoc; Du, Bin; Geduld, Heike; Gee, Patrick; Haider, Muhammad; Nerina, Harley; Hashimi, Madiha; Jehan, Fyezah; Hui, David; Hunt, Beverley J; Ismail, Mohamed; Kabra, Sushil; Kanda, Seema; Kawano-Dourado, Leticia; Kim, Yae-Jean; Kissoon, Niranjan; Krishna, Sanjeev; Kwizera, Arthur; Lisboa, Thiago; Leo, Yee-Sin; Mahaka, Imelda; Hela, Manai; Migliori, Giovanni Battista; Mino, Greta; Nsutebu, Emmanuel; Pshenichnaya, Natalia; Qadir, Nida; Ranganathan, Shalini Sri; Sabzwari, Saniya; Sarin, Rohit; Shankar-Hari, Manu; Sharland, Michael.
Afiliação
  • Lamontagne F; Université de Sherbrooke, Centre de recherche due CHU de Sherbrooke, Sherbrooke, Quebec, Canada
  • Stegemann M; Not guideline development group member; resource for methodology, systematic review, and content support
  • Agarwal A; Charité ­ Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Infectious Diseases, Respiratory Medicine and Critical Care, Berlin, Germany
  • Agoritsas T; Not guideline development group member; resource for methodology, systematic review, and content support
  • Siemieniuk R; Division of General Internal Medicine, McMaster University, Hamilton, Ontario, Canada
  • Rochwerg B; Not guideline development group member; resource for methodology, systematic review, and content support
  • Bartoszko J; Division of General Internal Medicine & Division of Clinical Epidemiology, University Hospitals of Geneva, Geneva, Switzerland
  • Askie L; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada
  • Macdonald H; MAGIC Evidence Ecosystem Foundation, Oslo, Norway
  • Al-Maslamani M; Not guideline development group member; resource for methodology, systematic review, and content support
  • Amin W; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada
  • Da Silva ARA; Department of Medicine, McMaster University, Hamilton, Ontario, Canada
  • Barragan FAJ; Not guideline development group member; resource for methodology, systematic review, and content support
  • Bausch FJ; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada
  • Burhan E; Department of Medicine, McMaster University, Hamilton, Ontario, Canada
  • Cecconi M; Not guideline development group member; resource for methodology, systematic review, and content support
  • Chacko B; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada
  • Chanda D; Not guideline development group member; resource for methodology, systematic review, and content support
  • Dat VQ; World Health Organization, Geneva, Switzerland
  • Du B; Not guideline development group member; resource for methodology, systematic review, and content support
  • Geduld H; The BMJ, London, UK
  • Gee P; Not guideline development group member; resource for methodology, systematic review, and content support
  • Haider M; Communicable Disease Center, Qatar
  • Nerina H; Ministry of Health and Population, Cairo, Egypt
  • Hashimi M; Departamento de Materno Infantil, Universidade Federal Fluminense, Brazil
  • Jehan F; Antioquia University Medellín, Colombia
  • Hui D; Geneva University Hospital, Switzerland
  • Hunt BJ; Infection Division, Department of Pulmonology and Respiratory Medicine, Faculty of Medicine Universitas Indonesia
  • Ismail M; Department of Anesthesia and Intensive Care Medicine, Humanitas Clinical and Research Center-IRCCS, Rozzano, Italy
  • Kabra S; Division of Critical Care Medicine at Christian Medical College, Vellore, India
  • Kanda S; Adult Infectious Disease Centre, University Teaching Hospital, Lusaka, Zambia
  • Kawano-Dourado L; Department of Infectious Diseases, Hanoi Medical University, Hanoi, Vietnam
  • Kim YJ; Peking Union Medical College Hospital, Beijing, China
  • Kissoon N; Division of Emergency Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa
  • Krishna S; USA
  • Kwizera A; Ministry of Health, Afghanistan
  • Lisboa T; Royal Melbourne Hospital, Melbourne, Australia
  • Leo YS; Ziauddin University, Karachi, Pakistan
  • Mahaka I; Aga Khan University, Karachi, Pakistan
  • Hela M; Stanley Ho Centre for Emerging Infectious Diseases, Chinese University of Hong Kong, Hong Kong SAR, China
  • Migliori GB; Guy's & St Thomas' NHS Foundation Trust, London, UK
  • Mino G; Indira Gandhi Memorial Hospital, Maldives
  • Nsutebu E; All India Institute of Medical Sciences, New Delhi, India
  • Pshenichnaya N; McMaster University (alumnus)
  • Qadir N; Pulmonary Division, Heart Institute (InCor)- HCFMUSP, Medical School, University of Sao Paulo, São Paulo, Brazil and Research Institute, Hospital do Coração (HCor), São Paulo, Brazil
  • Ranganathan SS; Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Republic of Korea
  • Sabzwari S; Department of Paediatrics and Emergency Medicine, University of British Columbia, Vancouver, Canada
  • Sarin R; St George's University of London, UK
  • Shankar-Hari M; Department of Anaesthesia and Critical Care, College of Health Sciences, Makerere University, Kampala, Uganda
  • Sharland M; Coraçao Hospital, São Paulo, Brazil
BMJ ; 372: n526, 2021 03 01.
Article em En | MEDLINE | ID: mdl-33649077
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Medição de Risco / Quimioprevenção / COVID-19 / Hidroxicloroquina Tipo de estudo: Etiology_studies / Guideline / Prognostic_studies Aspecto: Ethics Limite: Humans Idioma: En Revista: BMJ Assunto da revista: MEDICINA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Canadá País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Medição de Risco / Quimioprevenção / COVID-19 / Hidroxicloroquina Tipo de estudo: Etiology_studies / Guideline / Prognostic_studies Aspecto: Ethics Limite: Humans Idioma: En Revista: BMJ Assunto da revista: MEDICINA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Canadá País de publicação: Reino Unido